New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of ...

Elizabeth Holmes is back in the spotlight thanks to a new A24 documentary from Nathan Fielder and Lance Oppenheim. Here’s ...

Federal prosecutors say Ryan Sherman, 36, would take innocuous photos of kids and run them through AI software to make and ...

A failure to perform a primary obligation under a contract is a breach, which gives rise to a secondary obligation on the ...

Brian Tenney, who owned the now-shuttered West Coast Game Park Safari in Bandon, was sentenced Tuesday afternoon to seven ...

NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.

The "Epidermolysis Bullosa - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The epidermolysis bullosa market is entering a period of ...

The Japanese yen's turmoil threatened to hit Americans with higher prices for mortgages, investments and borrowing costs, as ...

NanoViricides announces Phase II clinical trial for oral Ebola drug NV-387 registered in Pan African database, ready to treat patients amid growing DRC outbreak.

A long-vacant Pilsen lot is finally getting built on — three units, a roof deck, and EV-ready parking included.

(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment ...